Noticias de LSTA_US

Noticias del mercado

Últimas noticias sobre LSTA_US — 66 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: LSTA_US ✕ 66 resultados
23/04/2026 LSTA_US — sonla.gov.vn
Lisata Therapeutics (LSTA) Market Dynamics | Lisata Therapeutics posts 10.2% EPS beat, 170B revenue - Expert Entry Points
23/04/2026 LSTA_US — laocai.gov.vn
Lisata Therapeutics (LSTA) Market Dynamics | Lisata Therapeutics posts 10.2% EPS beat, 170B revenue - Expert Entry Points
23/04/2026 LSTA_US — haiphong.gov.vn
Lisata Therapeutics (LSTA) Market Dynamics | Lisata Therapeutics posts 10.2% EPS beat, 170B revenue - Retail Trader Ideas
23/04/2026 LSTA_US — Xã Thanh Hà ES ← EN
Dinámica del mercado de Lisata Therapeutics (LSTA) | Lisata Therapeutics registra un beneficio por acción del 10,2% y unos ingresos de 170.000 millones - Expert Entry Points
22/04/2026 LSTA_US — MSN ES ← EN
Lisata describe los preparativos del ensayo de certepetida de fase III y apunta a un año 2026 lleno de hitos en medio de alianzas ampliadas

Lisata outlines Phase III certepetide trial preparations and targets milestone-rich 2026 amid expanded alliances

22/04/2026 LSTA_US — syt.laocai.gov.vn
Lisata Therapeutics (LSTA) Market Dynamics | Lisata Therapeutics posts 10.2% EPS beat, 170B revenue - Retail Trader Ideas
20/04/2026 LSTA_US — GuruFocus ES ← EN
Lisata Therapeutics Inc (LSTA) - Medidas de valoración y estadísticas financieras
15/04/2026 LSTA_US — Stock Titan
Financing delays put Lisata Therapeutics (LSTA) tender offer by Kuva Labs in doubt
15/04/2026 LSTA_US — TradingView
Lisata Therapeutics says Kuva Labs seeking new financing, tender offer not yet commenced
15/04/2026 LSTA_US — TipRanks
Lisata Therapeutics extends deadline for Kuva tender offer
15/04/2026 LSTA_US — newser.com
Lisata Therapeutics (LSTA) Market Dynamics | Lisata Therapeutics posts 10.2% EPS beat, 170B revenue - Financial Health
15/04/2026 LSTA_US — newser.com
Lisata Therapeutics posts 10.2% EPS beat, 170B revenue - Community Volume Signals
15/04/2026 LSTA_US — newser.com
Lisata Therapeutics posts 10.2% EPS beat, 170B revenue - Attention Driven Stocks
15/04/2026 LSTA_US — newser.com
Lisata Therapeutics (LSTA) Market Dynamics | Lisata Therapeutics posts 10.2% EPS beat, 170B revenue - Crowd Breakout Signals
15/04/2026 LSTA_US — newser.com
Lisata Therapeutics (LSTA) Market Dynamics | Lisata Therapeutics posts 10.2% EPS beat, 170B revenue - FCF Yield
12/04/2026 LSTA_US — MSN
Lisata Therapeutics to be acquired by Kuva Labs in $4.00-per-share cash deal
06/04/2026 LSTA_US — newser.com
Is Lisata Therapeutics (LSTA) Stock Slowing Down | Price at $5.01, Down 0.20% - Investment Signal Network
06/04/2026 LSTA_US — newser.com
Is Lisata Therapeutics (LSTA) Stock Slowing Down | Price at $5.01, Down 0.20% - Upside Potential
06/04/2026 LSTA_US — newser.com
Is Lisata Therapeutics (LSTA) Stock Slowing Down | Price at $5.01, Down 0.20% - Micro Trends
06/04/2026 LSTA_US — newser.com
Is Lisata Therapeutics (LSTA) Stock Slowing Down | Price at $5.01, Down 0.20% - Analyst Upgrade

Página 2 de 4

keyboard_arrow_up